Your browser doesn't support javascript.
loading
Comprehensive variant spectrum of the CNGA3 gene in patients affected by achromatopsia.
Solaki, Maria; Baumann, Britta; Reuter, Peggy; Andreasson, Sten; Audo, Isabelle; Ayuso, Carmen; Balousha, Ghassan; Benedicenti, Francesco; Birch, David; Bitoun, Pierre; Blain, Delphine; Bocquet, Beatrice; Branham, Kari; Català-Mora, Jaume; De Baere, Elfride; Dollfus, Helene; Falana, Mohammed; Giorda, Roberto; Golovleva, Irina; Gottlob, Irene; Heckenlively, John R; Jacobson, Samuel G; Jones, Kaylie; Jägle, Herbert; Janecke, Andreas R; Kellner, Ulrich; Liskova, Petra; Lorenz, Birgit; Martorell-Sampol, Loreto; Messias, André; Meunier, Isabelle; Belga Ottoni Porto, Fernanda; Papageorgiou, Eleni; Plomp, Astrid S; de Ravel, Thomy J L; Reiff, Charlotte M; Renner, Agnes B; Rosenberg, Thomas; Rudolph, Günther; Salati, Roberto; Sener, E Cumhur; Sieving, Paul A; Stanzial, Franco; Traboulsi, Elias I; Tsang, Stephen H; Varsanyi, Balázs; Weleber, Richard G; Zobor, Ditta; Stingl, Katarina; Wissinger, Bernd.
Afiliação
  • Solaki M; Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
  • Baumann B; Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
  • Reuter P; Centre for Ophthalmology, Institute for Ophthalmic Research, University of Tübingen, Tübingen, Germany.
  • Andreasson S; Department of Ophthalmology, University Hospital Lund, Lund, Sweden.
  • Audo I; Sorbonne Université, INSERM, CNRS, Institut de la Vision, Paris, France.
  • Ayuso C; CHNO des Quinze-Vingts, Centre de Référence Maladies Rares REFERET, and INSERM-DGOS CIC1423, Paris, France.
  • Balousha G; Department of Genetics & Genomics, Instituto de Investigación Sanitaria - Fundación Jiménez Díaz University Hospital - Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Benedicenti F; Center for Biomedical Network Research on Rare Diseases (CIBERER), ISCIII, Madrid, Spain.
  • Birch D; Department of Pathology and Histology, Faculty of Medicine, Al-Quds University, Eastern Jerusalem, Palestine.
  • Bitoun P; Clinical Genetics Service and South Tyrol Coordination Center for Rare Diseases, Department of Pediatrics, Regional Hospital of Bolzano, Bolzano, Italy.
  • Blain D; Retina Foundation of the Southwest, Dallas, Texas, USA.
  • Bocquet B; Genetique Medicale, CHU Paris Nord, Hopital Jean Verdier, Bondy Cedex, France.
  • Branham K; National Eye Institute/NEI, Bethesda, Maryland, USA.
  • Català-Mora J; National Reference Centre for Inherited Sensory Diseases, Institute for Neurosciences of Montpellier (INM), University of Montpellier, INSERM, Montpellier, France.
  • De Baere E; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Dollfus H; Unitat de Distròfies Hereditàries de Retina Hospital Sant Joan de Déu, Barcelona, Esplugues de Llobregat, Spain.
  • Falana M; Department of Biomolecular Medicine, Center for Medical Genetics, Ghent University and Ghent University Hospital, Ghent, Belgium.
  • Giorda R; CARGO, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
  • Golovleva I; U-1112, Inserm, Faculté de Médecine, Université de Strasbourg, Strasbourg, France.
  • Gottlob I; Department of Pathology and Histology, Faculty of Medicine, Al-Quds University, Eastern Jerusalem, Palestine.
  • Heckenlively JR; Molecular Biology Laboratory, Scientific Institute IRCCS E. Medea, Bosisio Parini, Lecco, Italy.
  • Jacobson SG; Department of Medical Biosciences/Medical and Clinical Genetics, University of Umea, Umea, Sweden.
  • Jones K; The University of Leicester Ulverscroft Eye Unit, Leicester Royal Infirmary, Leicester, UK.
  • Jägle H; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, University of Michigan, Ann Arbor, Michigan, USA.
  • Janecke AR; Department of Ophthalmology, Perelman School of Medicine, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Kellner U; Retina Foundation of the Southwest, Dallas, Texas, USA.
  • Liskova P; Department of Ophthalmology, University of Regensburg, Regensburg, Germany.
  • Lorenz B; Institute of Human Genetics, Medical University of Innsbruck, Innsbruck, Austria.
  • Martorell-Sampol L; Zentrum für Seltene Netzhauterkrankungen, AugenZentrum Siegburg, MVZ Augenärztliches Diagnostik- und Therapiecentrum Siegburg GmbH, Siegburg, Germany.
  • Messias A; RetinaScience, Bonn, 53192, Germany.
  • Meunier I; Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Belga Ottoni Porto F; Department of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Papageorgiou E; Department of Ophthalmology, Justus-Liebig University Giessen, Giessen, Germany.
  • Plomp AS; Department of Ophthalmology, Universitaetsklinikum Bonn, Bonn, Germany.
  • de Ravel TJL; Genetica Molecular-Edifici Docent, Hospital Sant Joan de Deu, Esplugues-Barcelona, Spain.
  • Reiff CM; Department of Ophthalmology, Otorhinolaryngology, and Head and Neck Surgery, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil.
  • Renner AB; National Reference Centre for Inherited Sensory Diseases, Montpellier University Hospital, University of Montpellier, Montpellier, France.
  • Rosenberg T; Sensgene Care Network, France.
  • Rudolph G; INRET Clínica e Centro de Pesquisa, IEP Santa Casa Belo Horizonte, Belo Horizonte, MG, Brazil.
  • Salati R; Department of Ophthalmology, University Hospital of Larissa, Mezourlo, Larissa, Greece.
  • Sener EC; Department of Human Genetics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Sieving PA; Centre for Medical Genetics, University Hospital Brussels, Brussels, Belgium.
  • Stanzial F; Augenarztpraxis am Stadttheater, Freiburg, Germany.
  • Traboulsi EI; Augenarztpraxis Regensburg, Regensburg, Germany.
  • Tsang SH; Department of Ophthalmology, National Eye Clinic, Glostrup Hospital, Glostrup, Denmark.
  • Varsanyi B; University Eye Hospital, Ludwig Maximilians University, Munich, Germany.
  • Weleber RG; Scientific Institute, IRCCS Eugenio Medea, Pediatric Ophthalmology Unit, Bosisio Parini, Lecco, Italy.
  • Zobor D; Strabismus and Pediatric Ophthalmology, Private Practice, Ankara, Turkey.
  • Stingl K; Center for Ocular Regenerative Therapy, School of Medicine, University of California Davis, Sacramento, USA.
  • Wissinger B; Clinical Genetics Service and South Tyrol Coordination Center for Rare Diseases, Department of Pediatrics, Regional Hospital of Bolzano, Bolzano, Italy.
Hum Mutat ; 43(7): 832-858, 2022 07.
Article em En | MEDLINE | ID: mdl-35332618
ABSTRACT
Achromatopsia (ACHM) is a congenital cone photoreceptor disorder characterized by impaired color discrimination, low visual acuity, photosensitivity, and nystagmus. To date, six genes have been associated with ACHM (CNGA3, CNGB3, GNAT2, PDE6C, PDE6H, and ATF6), the majority of these being implicated in the cone phototransduction cascade. CNGA3 encodes the CNGA3 subunit of the cyclic nucleotide-gated ion channel in cone photoreceptors and is one of the major disease-associated genes for ACHM. Herein, we provide a comprehensive overview of the CNGA3 variant spectrum in a cohort of 1060 genetically confirmed ACHM patients, 385 (36.3%) of these carrying "likely disease-causing" variants in CNGA3. Compiling our own genetic data with those reported in the literature and in public databases, we further extend the CNGA3 variant spectrum to a total of 316 variants, 244 of which we interpreted as "likely disease-causing" according to ACMG/AMP criteria. We report 48 novel "likely disease-causing" variants, 24 of which are missense substitutions underlining the predominant role of this mutation class in the CNGA3 variant spectrum. In addition, we provide extensive in silico analyses and summarize reported functional data of previously analyzed missense, nonsense and splicing variants to further advance the pathogenicity assessment of the identified variants.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Defeitos da Visão Cromática / Canais de Cátion Regulados por Nucleotídeos Cíclicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Defeitos da Visão Cromática / Canais de Cátion Regulados por Nucleotídeos Cíclicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Ano de publicação: 2022 Tipo de documento: Article